Vitamin D deficiency in various breast cancer subtypes and its impact on response to neoadjuvant chemotherapy in operable breast cancer

被引：0
|
作者：
Raman, R. [1 ]
Link, B. K. [1 ]
Mott, S. L. [1 ]
Schroeder, M. C. [1 ]
Thomas, A. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-48
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Limitations of "Classic" Risk Factors to Predict Neoadjuvant Chemotherapy Response for Operable Breast Cancer
    Zografos, Georgios C.
    Ziogas, Dimosthenis
    WORLD JOURNAL OF SURGERY, 2009, 33 (07) : 1545 - 1546
  • [42] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [43] Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
    Ignatiadis, Michail
    Singhal, Sandeep K.
    Desmedt, Christine
    Haibe-Kains, Benjamin
    Criscitiello, Carmen
    Andre, Fabrice
    Loi, Sherene
    Piccart, Martine
    Michiels, Stefan
    Sotiriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1996 - 2004
  • [44] Identifying novel breast cancer subtypes effect on clinical response to neoadjuvant chemotherapy
    Bhatt, N.
    Fiuza-Castinieria, C.
    Murphy, S.
    O'Connor, M.
    O'Donoghue, G. T.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 22 - 22
  • [45] Neoadjuvant chemotherpay for operable breast cancer
    Green, M
    Hortobagyi, GN
    ONCOLOGY-NEW YORK, 2002, 16 (07): : 871 - +
  • [46] Prediction of response to primary chemotherapy for operable breast cancer
    Colleoni, M
    Orvieto, E
    Nolé, F
    Orlando, L
    Minchella, I
    Viale, G
    Peruzzotti, G
    Robertson, C
    Noberasco, C
    Galimberti, V
    Sacchini, V
    Veronesi, P
    Zurrida, S
    Orecchia, R
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) : 574 - 579
  • [47] Vitamin D level impacts odds of pathologic complete response following neoadjuvant therapy in operable breast cancer
    Thomas, A.
    Thezenas, S.
    Mott, S. L.
    Raman, R.
    Viala, M.
    Pouderoux, S.
    Schroeder, M. C.
    Lamy, P-J
    Jacot, W.
    CANCER RESEARCH, 2017, 77
  • [48] Impact of Breast Cancer Molecular Subtypes on Local Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Meyers, M. O.
    Klauber-DeMore, N.
    Ollila, D. W.
    Amos, K. D.
    Calvo, B. F.
    Moore, D. T.
    Perou, C. M.
    Dees, E. C.
    Carey, L. A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 59 - 59
  • [49] Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Meyers, Michael O.
    Klauber-DeMore, Nancy
    Ollila, David W.
    Amos, Keith D.
    Moore, Dominic T.
    Drobish, Amy A.
    Burrows, Emily M.
    Dees, E. Claire
    Carey, Lisa A.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (10) : 2851 - 2857
  • [50] Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience
    Abdel-Bary, N.
    El-Kased, A. F.
    Aiad, H. A. Z.
    ECANCERMEDICALSCIENCE, 2009, 3
12345